Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research. Dr. Harding's research is also supported with generous funding from the Huntington Society of Canada and the CHDI Foundation. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.

In a ground-breaking initiative, scientists around the world from SGC, UNC-Catalyst and MIVEGEC are sharing their laboratory notebooks live, online. We introduce our experiments at openlabnotebooks.org with links to experimental details at zenodo.org. We believe that making our research, data, and protocols available on a day-to-day basis will generate scientific ideas and discussions, avoid redundancy, foster collaborations, and accelerate progress. Our hope is that this initiative will inspire others to follow. Join us!